Mersana Therapeutics, Inc.
MRSNDelisted Jan 6, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001442836
Mersana Therapeutics, Inc. was delisted on Jan 6, 2026; its insiders filed their last Form 4 on Jan 6, 2026; 51 institutions reported holding it in 13F filings for Q4 2025, worth $64.8M in total; no superinvestor held it.
Q3 2022 vs. Q2 2022
How the institutions holding Mersana Therapeutics, Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 126 | 152 | +26 |
| Shares | 88.3M | 92.2M | +3.90M (+4.4%) |
| Value | $408.0M | $623.4M | +$215.4M (+52.8%) |
New holders (40)
Institutions that held Mersana Therapeutics, Inc. at the end of Q3 2022 but not at the end of Q2 2022.
Sold out (14)
Institutions that held Mersana Therapeutics, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Woodline Partners LP | 3,161,576 | $14.6M |
| Wellington Management Group LLP | 480,644 | $2.22M |
| EcoR1 Capital, LLC | 310,960 | $1.44M |
| Graham Capital Management, L.P. | 203,067 | $938.0K |
| Caxton Associates LP | 47,915 | $221.0K |
| Partners Group Holding AG | 37,473 | $173.0K |
| HSBC Holdings PLC | 18,737 | $85.0K |
| Victory Capital Management Inc | 12,537 | $58.0K |
| Walleye Capital LLC | 10,264 | $47.0K |
| Washington University | 9,367 | $43.0K |
| PEAK6 Investments LLC | 5,000 | $16.4K |
| Quantbot Technologies LP | 954 | $4.00K |
| Captrust Financial Advisors | 226 | $1.00K |
| Dark Forest Capital Management LP | 311 | $1.00K |